Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sec31 homolog B (SEC31B) is a mammalian component of the COPII vesicle coat, homologous to yeast Sec31p and closely related to mammalian Sec31A. SEC31B is widely expressed in human tissues, especially enriched in cerebellum and testis, and is involved in mediating vesicular traffic from the endoplasmic reticulum to the Golgi apparatus as part of the COPII complex. Alternative splicing gives rise to multiple isoforms: a full-length form (Sec31B-F) that functions in the formation and dynamics of COPII vesicle coats, and a truncated form (Sec31B-T) whose function is less well understood. The protein contains WD repeats and interacts with other COPII proteins such as Sec13 and Sec23/24, playing a role in the early secretory pathway. Currently, there is no evidence that SEC31B is a direct therapeutic target, is involved in specific diseases, or interacts with clinically used drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sec31 homolog B, COPII component (SEC31B).